Author:
Boyd Theresa M.,Lockhart Evelyn,Welsby Ian
Publisher
Springer Berlin Heidelberg
Reference150 articles.
1. AABB (2013) Circular of information for the use of human blood and blood components. In: Cross AR (ed) Bethesda.
http://www.aabb.org/resources/bct/Documents/coi_ct1013.pdf
. Last accessed 19 May 2014
2. AABB (2013) AABB Revises and Clarifies TRALI Risk Reduction Requirements.
http://www.aabb.org/sa/standards/Pages/revised-trali-risk-reduction-requirements.aspx
. Accessed 1 Oct 2013
3. Ageno W, Gallus AS, Wittkowsky A, Crowther M, Hylek EM, Palareti G (2012) Oral anticoagulant therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:e44S–e88S
4. Alvarez-Larran A, Del Rio J, Ramirez C, Albo C, Pena F, Campos A, Cid J, Muncunill J, Sastre JL, Sanz C, Pereira A (2004) Methylene blue-photoinactivated plasma vs. fresh-frozen plasma as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. Vox Sang 86:246–251
5. Ansell J, Hirsh J, Hylek E, Jacobson A, Crowther M, Palareti G (2008) Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:160S–198S
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献